Our Pricing

Semaglutide from GPhC Registered UK Pharmacy

Published on: June 03, 2026

Looking to buy semaglutide online UK pharmacy with confidence? Cured Pharmacy offers genuine UK-licensed semaglutide treatments including Wegovy and Saxenda, with transparent upfront pricing from £135.00 free clinical consultation under 3 minutes, and discreet next-day delivery across the UK. All prescriptions are assessed by our UK-registered clinical team led by superintendent pharmacist Tarun Kumar (GPhC 2233073).

How Semaglutide Works for Weight Loss

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist licensed by the MHRA for chronic weight management in adults with obesity or overweight with weight-related comorbidities [1]. It mimics the action of natural GLP-1 hormone, which regulates appetite by acting on areas of the brain that control food intake and satiety.

In the landmark STEP 1 trial, participants using semaglutide 2.4mg weekly achieved an average body weight reduction of 14.9% over 68 weeks, compared to 2.4% with placebo [1]. The medication works by slowing gastric emptying, reducing hunger signals, and increasing feelings of fullness after meals, making it easier to maintain a reduced-calorie diet.

Clinical data demonstrates that semaglutide's effects extend beyond appetite suppression — patients also experienced improvements in cardiovascular risk markers including blood pressure, cholesterol levels, and inflammatory markers [2]. These metabolic benefits contribute to the overall health improvements observed during treatment.

Semaglutide Treatments Available at Cured Pharmacy

We dispense two semaglutide-based treatments at Cured Pharmacy: Wegovy (semaglutide 2.4mg) for weight management and Saxenda (liraglutide, a related GLP-1 agonist). Both are prescription-only medicines that require clinical assessment by a UK prescriber before dispensing.

Wegovy is administered as a once-weekly subcutaneous injection, starting at a low dose and gradually increasing over 16-20 weeks to the maintenance dose of 2.4mg. This gradual titration schedule helps minimise gastrointestinal side effects whilst your body adjusts to the medication [3]. At Cured Pharmacy, Wegovy is available with transparent pricing and includes all necessary injection supplies.

Saxenda contains liraglutide, an earlier GLP-1 receptor agonist that requires daily injection rather than weekly dosing. Whilst both medications work through similar mechanisms, the dosing frequency and clinical trial outcomes differ, which your prescriber will discuss during your consultation to determine the most suitable option for your circumstances.

Choosing Between Wegovy and Saxenda

Your UK prescriber will consider several factors when recommending treatment, including your BMI, weight loss goals, medical history, current medications, and lifestyle preferences. Wegovy's once-weekly dosing often suits patients seeking convenience, whilst Saxenda's daily injection allows for more frequent dose adjustments if needed. Both treatments require commitment to dietary changes and increased physical activity for optimal results, as medication alone is not sufficient for sustained weight management [4].

Buy Semaglutide Online UK: The Cured Pharmacy Process

Purchasing semaglutide through Cured Pharmacy follows a straightforward, fully regulated process that complies with MHRA and GPhC guidelines. You'll begin by completing a free online consultation that takes under 3 minutes, providing information about your medical history, current health status, and weight management goals.

Our UK-registered prescribers review every consultation individually — there are no automated approvals. If semaglutide is clinically appropriate and safe for you, a prescription will be issued and sent electronically to our dispensary. Your medication is then prepared by our GPhC-registered pharmacy team and dispatched in 100% discreet packaging with next-day delivery options available across the UK.

Transparency is central to our service. Unlike some providers, we display treatment prices upfront before you begin your consultation, so you'll know exactly what to expect. There are no hidden fees, and our prices are amongst the most competitive in the UK market. If your prescriber determines that semaglutide isn't suitable, they may recommend alternative weight management options from our range, or advise you to consult your GP for further assessment.

Ongoing Clinical Support

Weight management with semaglutide requires regular monitoring and follow-up. Our clinical team provides ongoing support throughout your treatment journey, with follow-up consultations to assess your progress, manage any side effects, and adjust dosing as needed. You can contact our pharmacy team on (+44) 116 4646009 during business hours with any questions about your medication, injection technique, or side effects.

Semaglutide UK Prescription Requirements and Eligibility

Semaglutide for weight management is licensed in the UK for adults with a BMI of 30 kg/m² or greater, or 27 kg/m² or greater with at least one weight-related comorbidity such as type 2 diabetes, hypertension, or dyslipidaemia [5]. NICE guidance recommends considering GLP-1 receptor agonists as part of a comprehensive weight management programme that includes dietary modification and increased physical activity.

During your online consultation, our prescribers will assess whether you meet the clinical criteria for semaglutide treatment. This includes reviewing your weight history, previous weight loss attempts, current medications, and any contraindications such as personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 [5].

Certain medical conditions may preclude semaglutide use or require additional monitoring. These include severe gastrointestinal disease, diabetic retinopathy, renal impairment, and pregnancy or breastfeeding. Our prescribers follow MHRA prescribing guidelines strictly to ensure patient safety, and will only issue a prescription when it is clinically appropriate to do so.

Semaglutide Weight Loss UK: What to Expect

Weight loss with semaglutide occurs gradually over several months as you progress through the dose escalation schedule. Most patients begin noticing appetite reduction within the first few weeks, though significant weight changes typically become apparent after 12-16 weeks of treatment at therapeutic doses [1].

Clinical trial data shows that the majority of weight loss occurs within the first 60 weeks of treatment, with patients continuing on the maintenance dose achieving sustained weight reduction when combined with lifestyle modifications [2]. It's important to understand that individual responses vary — some patients may achieve greater weight loss than the trial averages, whilst others may experience more modest results.

Common side effects during the initial weeks include nausea, diarrhoea, constipation, and abdominal discomfort. These gastrointestinal effects are usually mild to moderate and diminish as your body adjusts to the medication [3]. The gradual dose titration schedule is specifically designed to minimise these effects. If side effects become troublesome, your prescriber may adjust your titration schedule or recommend supportive measures.

Maximising Your Results

Semaglutide is most effective when used as part of a comprehensive weight management approach. This includes adopting a reduced-calorie diet rich in whole foods, increasing physical activity to at least 150 minutes of moderate exercise weekly, improving sleep quality, and managing stress. Our clinical team can provide guidance on evidence-based lifestyle strategies that complement your medication, though we recommend working with a registered dietitian for personalised nutritional advice [6].

Why Choose Cured Pharmacy for Semaglutide UK

As a fully registered UK pharmacy (GPhC 9012511) operating under the supervision of superintendent pharmacist Tarun Kumar (GPhC 2233073), we adhere to the highest standards of pharmaceutical care and regulatory compliance. Every medication we dispense is sourced through licensed UK wholesalers and stored in our temperature-controlled facility to maintain product integrity.

We guarantee the lowest prices in the UK for semaglutide treatments, with Wegovy available from £135.00 and transparent pricing displayed before you begin your consultation. Our commitment to affordability doesn't compromise quality — you'll receive the same genuine, UK-licensed medications available through any registered pharmacy, but at competitive rates that make long-term treatment more accessible.

Our service combines clinical expertise with convenience. Free online consultations are reviewed by experienced UK prescribers who specialise in weight management and metabolic health. Discreet packaging ensures your privacy, and our customer service team is available to answer questions throughout your treatment journey. We've helped thousands of UK patients access evidence-based weight management treatments safely and affordably.

Scientific References

1. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
2. Davies, M., et al. (2021). Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. The Lancet, 397(10278), 971–984. https://doi.org/10.1016/S0140-6736(21)00213-0 [accessed 13 August 2026]
3. Rubino, D., et al. (2021). Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA, 325(14), 1414–1425. https://doi.org/10.1001/jama.2021.3224 [accessed 13 August 2026]
4. Wadden, T. A., et al. (2021). Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity: The STEP 3 Randomized Clinical Trial. JAMA, 325(14), 1403–1413. https://doi.org/10.1001/jama.2021.1831 [accessed 13 August 2026]
5. Medicines and Healthcare products Regulatory Agency. (2022). Wegovy 0.25 mg solution for injection in pre-filled pen - Summary of Product Characteristics. GOV.UK. https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency [accessed 13 August 2026]
6. National Institute for Health and Care Excellence. (2023). Obesity: identification, assessment and management (CG189). NICE. https://www.nice.org.uk/guidance/cg189 [accessed 13 August 2026]
7. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
8. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
9. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Semaglutide is a prescription-only medicine licensed for chronic weight management in adults with obesity or overweight with weight-related comorbidities. Individual results may vary. Common side effects include gastrointestinal symptoms. This content does not replace professional medical consultation.